PT18
INVESTIGATION OF THE RELATIONSHIP BETWEEN SARCOPENIC OBESITY AND URINARY INCONTINENCE
N. H. Önür1, T. Erdoğan1, D. Sezer1, S. Özkök1, Z. Fetullahoğlu Durmuş1, E. Aşcı Civelek1, Ö. Can Ceylan1, E. Pınar1, Z. Şahin Tırnova1, S. S. Güven1, D. Seyithanoğlu1,*, G. Bahat1, M. A. Karan1
1Istanbul University Istanbul Faculty of Medicine, Istanbul, Türkiye
Rationale: Sarcopenic obesity is a condition characterized by decreased muscle mass and strength along with an increased body fat percentage. While previous studies have separately examined the relationship between sarcopenia and obesity with urinary incontenence (UI). This study aimed to evaluate the relationship between sarcopenic obesity and UI.
Methods: This study included 1197 female patients aged 60 and older in a geriatric’s outpatient clinic between November 2012 and June 2024. Body composition was measured using BIA, and muscle strength was assessed using handgrip strength. The skeletal muscle mass index was adjusted for body weight. Sarcopenic obesity was defined using threshold values specific to the Turkish population, incorporating low muscle strength, low muscle mass, and high fat percentage. Patients were classified into four different phenotypic groups based on body composition: non-sarcopenic non-obese, sarcopenic non-obese, sarcopenic obese, and non-sarcopenic obese. The prevalence of UI and its relationship with phenotypic groups were analyzed using multivariable logistic regression analysis.
Results: The mean age of the included patients was 74 years (60–99). The prevalence of sarcopenic obesity was 21%, while the prevalence of UI was 51.2%. UI was observed in 24.8% of the 251 (21%) patients with sarcopenic obesity. A significant difference in UI prevalence was found among the phenotypic groups classified by body composition (p<0.001). In multivariable regression analysis, sarcopenic obesity was independently associated with UI (p=0.008)(Table).
Image:
Conclusion: This study demonstrates that sarcopenic obesity is more strongly associated with UI than sarcopenia or obesity alone. Early recognition of sarcopenic obesity and targeted interventions may play a crucial role in mitigating the effects of UI or reducing its incidence.
Disclosure of Interest: None declared